Precigen (PGEN) Asset Utilization Ratio (2013 - 2026)
Precigen (PGEN) reported Asset Utilization Ratio of 0.19 for Q1 2026, up 496.96% year-over-year from 0.03 in Q1 2025, and up 420.9% quarter-over-quarter from 0.04 in Q4 2025.
Precigen (PGEN) Asset Utilization Ratio (2013 - 2026) Analysis & Trends
Precigen (PGEN) has 14 years of Asset Utilization Ratio data on file, last reported at 0.19 in Q1 2026.
- Asset Utilization Ratio for Q1 2026 came in at 0.19, up 496.96% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.19 (up 496.96% YoY), and the FY2025 annual result was 0.06, up 143.07% from the prior year.
- Asset Utilization Ratio climbed to 0.19 in Q1 2026 per PGEN's latest filing, from 0.04 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.19 in Q1 2026 and troughed at 0.06 in Q3 2023.
- A 5-year average of 0.02 and a median of 0.02 in 2024 frame the typical range for Asset Utilization Ratio.
- The sharpest annual moves came in 2023 and 2026: Asset Utilization Ratio plunged 57351.3% in 2023, then soared 496.96% in 2026.
- A 5-year view of Asset Utilization Ratio shows it stood at 0.02 in 2022, then soared by 211.63% to 0.02 in 2023, then surged by 41.48% to 0.03 in 2024, then soared by 32.25% to 0.04 in 2025, then soared by 420.9% to 0.19 in 2026.
- Business Quant data shows PGEN's Asset Utilization Ratio at 0.19 in Q1 2026, 0.04 in Q4 2025, and 0.02 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 0.55 |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 0.60 |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 1,422.00 |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 0.47 |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Precigen | 1.27 Bn | 1.27 Bn | 20.69 Mn | 0.19 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.19 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.02 |
| Jun 30, 2025 | 0.03 |
| Mar 31, 2025 | 0.03 |
| Dec 31, 2024 | 0.03 |
| Sep 30, 2024 | 0.04 |
| Jun 30, 2024 | 0.02 |
| Mar 31, 2024 | 0.02 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | -0.06 |
| Jun 30, 2023 | -0.05 |
| Mar 31, 2023 | -0.04 |
| Dec 31, 2022 | -0.02 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | 0.00 |
| Mar 31, 2022 | 0.01 |
| Dec 31, 2021 | 0.06 |
| Sep 30, 2021 | 0.13 |
| Jun 30, 2021 | 0.18 |